dactinomycin has been researched along with Lymphangioendothelioma, Malignant in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Subramanian, S; Wiltshaw, E | 1 |
| Chu, F; Kaufman, R; Kaufmann, T | 1 |
| Tragus, ET; Wagner, DE | 1 |
1 trial(s) available for dactinomycin and Lymphangioendothelioma, Malignant
| Article | Year |
|---|---|
Chemotherapy of sarcoma. A comparison of three regimens.
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Fibrosarcoma; Humans; Leiomyosarcoma; Lymphangiosarcoma; Methotrexate; Nitrogen Mustard Compounds; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1978 |
2 other study(ies) available for dactinomycin and Lymphangioendothelioma, Malignant
| Article | Year |
|---|---|
Post-mastectomy lymphangiosarcoma (Stewart-Treves syndrome): report of two long-term survivals.
Topics: Aged; Breast Neoplasms; Combined Modality Therapy; Dactinomycin; Female; Humans; Lymphangiosarcoma; Lymphedema; Mastectomy; Neoplasms, Multiple Primary; Postoperative Complications; Radiotherapy, High-Energy; Soft Tissue Neoplasms; Syndrome | 1991 |
Current therapy for postmastectomy lymphangiosarcoma.
Topics: Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Female; Humans; Lymphangiosarcoma; Mastectomy; Melphalan; Middle Aged | 1968 |